IKKα modulates metastatic activity by preventing Tight Junctions stabilization and collective cell migration

[eng] The IKKα kinase was previously found to activate multiple oncogenic and therapy-resistance pathways, including ATM/DDR, BRD4, and JAK/STAT3, independently of canonical NF-KB signaling. Here, we show that suppression of IKKα, either genetically or pharmacologically, imposes a pro- metastatic ac...

Descripción completa

Detalles Bibliográficos
Autor: Alvarez Villanueva, Daniel
Tipo de recurso: tesis doctoral
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/219676
Acceso en línea:https://hdl.handle.net/2445/219676
http://hdl.handle.net/10803/693992
Access Level:acceso abierto
Palabra clave:Càncer colorectal
Metàstasi
Proteïnes quinases
Colorectal cancer
Metastasis
Protein kinases
Descripción
Sumario:[eng] The IKKα kinase was previously found to activate multiple oncogenic and therapy-resistance pathways, including ATM/DDR, BRD4, and JAK/STAT3, independently of canonical NF-KB signaling. Here, we show that suppression of IKKα, either genetically or pharmacologically, imposes a pro- metastatic activity on colorectal cancer (CRC) patient-derived organoid (PDO) cells, which is linked to an increase in the protein levels of the tight junction protein ZO-1 and CLDN2, and a shift in their migratory mode towards collective migration. Analysis of single-cell (sc)RNAseq data revealed an accumulation of the tight junction signature in the metastatic populations. Specifically, PDO cells contain three distinct epithelial cell clusters (C2, C4 and C8) with concomitant enrichment of the tight junction and metastasis-associated EpiHR signatures, whose unique genetic signatures are upregulated upon depletion of IKKand enriched in PDO-derived metastases. CLDN2 inhibition or depletion abolishes the metastatic activity of IKKα KO PDO cells in vivo. By analyzing human paraffin- embedded CRC specimens, we have detected the presence of vascular tumor infiltrates with cluster- like or glandular phenotypes and high levels of ZO-1 and CLDN2-positive junctions. Collectively, our results suggest that high levels of tight junction proteins in CRC cells imposes a pro- metastatic collective CRC cell migration, which can be detected in the vascular infiltrates at diagnosis. We propose that after validation, this type of exploration could be standardized in the clinical routine.